Search results
Is Eli Lilly Stock A Buy After Weight-Loss Drug Succeeds In Sleep Apnea Patients?
Investor's Business Daily· 3 days agoBut others are coming and could rock Eli Lilly stock. Viking Therapeutics soared after its weight-...
Meet Eli Lilly's Secret Weapon in the Billion-Dollar Weight Loss Drug Market
Motley Fool via Yahoo Finance· 5 days agoThe Motley Fool recommends Novo Nordisk. The Motley Fool has a disclosure policy. Meet Eli Lilly's...
This Popular Weight Loss Drug May Help People With Sleep Apnea, Study Finds
Prevention via Yahoo News· 3 days agoZepbound, by Eli Lilly, may improve sleep apnea symptoms in those with the condition. Sleep experts...
Novo Nordisk (NYSE:NVO) and Eli Lilly (NYSE:LLY): Anti-Obesity Drug Market Could Reach Double...
The Wall Street Transcript· 3 hours agoCiti Research Health Care Analyst Andrew Baum, M.D., maintains a “buy” recommendation on GLP-1...
Dow Jones Futures Rise: Nvidia Leads 7 New Buys As Market Roars; Fed, Apple, Super Micro Loom
Investor's Business Daily· 6 minutes agoEli Lilly reports early Tuesday while Novo Nordisk is on tap before Thursday's open. Expect strong...
How one state is trying to make weight loss drugs cheaper
NBC Universal via AOL· 4 days agoWeight loss drugs aren't covered by insurance for North Carolina's state employees. The state is...
Weight loss drugs like Wegovy have taken the country by storm. But who can afford them?
USA TODAY· 4 days agoA late-stage study this month reported that the diabetes and weight loss drug tirzepatide also may...
Eli Lilly Just Announced More Good News: Time to Buy?
Motley Fool via Yahoo Finance· 9 hours agoHowever, occasionally, some drug therapies pay for the money invested in their development several...
3 Speculative Weight Loss Drug Stocks to Bet On for Big Gains
InvestorPlace· 5 days agoInvestors continue to search for the next big weight loss drug stocks following the success of Eli ...
...Changing Frugal Eating Habits - How Novo Nordisk/Eli Lilly's Weight Loss Drugs Reshaping Food...
Benzinga· 7 days agoA/S’s NVO Wegvoy (semaglutide) and Eli Lilly And Co’s LLY Zepbound (tirzepatide) have amassed...